
Ciaran O'Leary, BlueYard
Origins - Inside Venture Capital, Hosted by a GP and an LP
00:00
Exploring a Revolutionary Portfolio Company and Speculating on Blue Yard's Future
Exploring a portfolio company programming stem cells for animal-free food and new therapies, with potential for industry disruption. The discussion extends to Blue Yard's future, emphasizing their boutique nature and pursuit of cutting-edge technologies like quantum control chips.
Transcript
Play full episode